Meaning-centered psychotherapy for Mexican patients with advanced cancer
Trial of Meaning Centered Psychotherapy for Mexican Patients with Advanced Cancer
This project offers a Spanish-language meaning-centered psychotherapy program to help Mexican people with advanced cancer cope with depression, anxiety, and worries about mortality while finding peace and purpose.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11399205 on NIH RePORTER |
What this research studies
You would be offered a culturally adapted, meaning-centered therapy program designed to help people with advanced cancer deal with fears about death, uncertainty, and spiritual concerns. The program was adapted for Spanish-speaking Latinos and will be delivered by trained psycho-oncology staff in collaboration between Memorial Sloan Kettering and Mexico's National Cancer Institute (INCan). If you take part, you would attend therapy sessions at INCan and complete brief mood, meaning, and quality-of-life questionnaires before and after the therapy. The team will track changes in symptoms and wellbeing to see how the program works for Mexican patients.
Who could benefit from this research
Good fit: Ideal candidates are Spanish-speaking Mexican adults with advanced cancer who are experiencing depression, anxiety, or distress about meaning and the future and who receive care at or near the National Mexican Cancer Institute.
Not a fit: People without advanced cancer, those who do not speak Spanish, or patients with severe cognitive impairment or urgent medical needs may not benefit from this psychotherapy program.
Why it matters
Potential benefit: If successful, this therapy could reduce depression and anxiety and help patients with advanced cancer feel more meaning, peace, and purpose near the end of life.
How similar studies have performed: Meaning-centered psychotherapy has shown feasibility and benefits in prior trials and a pilot study with Spanish-speaking Latino patients, but it has not yet been tested specifically with Mexican cancer patients.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Costas-Muniz, Rosario — Sloan-Kettering Inst Can Research
- Study coordinator: Costas-Muniz, Rosario
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.